http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103432595-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5527f7b578dc59680f079a4fc2834a1
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
filingDate 2013-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16c5a3bfce3a6c481ded776d4c24e3a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73891a46c2908e5056f40aaf8833f8fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_695f06faac53d9952656082b587a9828
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54bbfc1ef95083943f3d440d0453859a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abef746d215028854778e985af6cd8a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ada1475a31ce7f1fb1485c4d5b46c041
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbec4ce63b75390ab906c1f14cbb406c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8d7b9f1943ca100bad7d610c3a7c163
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66a71fa462e53186734a866b4f9181e8
publicationDate 2015-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103432595-B
titleOfInvention Application of human miR-26b in preparation of drugs for inhibiting fat cell proliferation
abstract The invention belongs to the field of gene engineering and discloses the application of human miR-26b in the preparation of drugs for inhibiting fat cell proliferation. The invention provides a technical scheme of applying human miR-26b in the preparation of drugs for inhibiting fat cell proliferation. The study results provided in the invention show that the over-expression of human miR-26b in human fat cells can significantly inhibit the proliferation velocity and cell quantity of fat cells, and human miR-26b can be used to prepare drugs for inhibiting fat cell proliferation and drugs for weight loss.
priorityDate 2013-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011138457-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP04635
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP41773
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP26504
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCD4A9L7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9TKU7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ06SH2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08548
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534983
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA8WGN9
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP71276
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ47526
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ20449
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5U780
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0C0R3
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO00939
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0C0R4
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ673L6
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6A548
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ94818
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A3Q1M1X5
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0DV59
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ55EU1
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ94819
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID58190
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506960
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9NBX4
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ1KVQ9
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3034010
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ3UT41
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21329
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID553744
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO14746
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ27ID4
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO13339
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ93MW7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23070
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428054790
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID227292
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23071
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP61871
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23072
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ06163
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP61872
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO76332
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5HKP6
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ1PS67
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ20EU8
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO77448
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO70372
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ46666
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9SPU7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO59952
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0DV86
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5210
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ4KTA7
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68561600
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8LKW0
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21328
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0DV89
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19515
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9VG48
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ95SX7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0DV94
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19593

Total number of triples: 86.